id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-319864-t6ql9hz2	Lima, Amorce	Validation of a Modified CDC Assay and Performance Comparison with the NeuMoDx™ and DiaSorin® automated assays for Rapid Detection of SARS-CoV-2 in Respiratory Specimens	2020-11-11		.txt	text/plain	3053	105	52	f the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19 Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2 We are grateful to University of Texas Medical Branch for providing SARS CoV-2 RNA Template for the validation of the modified CDC SARS-CoV-2 assay. Our laboratory at Tampa General Hospital validated a modified version of the CDC assay following the FDA EUA guidelines and brought in commercial assays to help respond to the testing demand.	cache/cord-319864-t6ql9hz2.txt	txt/cord-319864-t6ql9hz2.txt
